VPC-70063

Catalog No. :
ACTRZY805
CAS No. :
13571-44-3
Molecular Formula :
C16H12F6N2S
Molecular Weight :
378.34

IUPAC Name:1-benzyl-3-(3,5-bis(trifluoromethyl)phenyl)thiourea

VPC-70063 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$125.00Login to see priceIn stockInquiry
100mg98%$213.00Login to see priceIn stockInquiry
250mg98%$405.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameVPC-70063
IUPAC Name1-benzyl-3-(3,5-bis(trifluoromethyl)phenyl)thiourea
Molecular FormulaC16H12F6N2S
Molecular Weight378.34
SMILESS=C(NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)NCC2=CC=CC=C2
InChI KeyPIQMVCPITQIXGJ-UHFFFAOYSA-N
SynonymThiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)-;VPC-70063;VPC70063,Anticancer,LNCaP,VPC 70063,inhibit,Myc-Max,UBE2C,Apoptosis,VPC-70063,c-Myc,PARP,AR-V7,Myc,Inhibitor,poly ADP ribose polymerase;1-benzyl-3-(3,5-bis(trifluoromethyl)phenyl)thiourea;VPC-70063, 10 mM in DMSO;N-[3,5-Bis(trifluoromethyl)phenyl]-N′-(phenylmethyl)thiourea
CAS No.13571-44-3

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACTRZY805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACTRZY805 route product structure diagram
    ACTRZY80513571-44-3 In Stock
Inquiry

2. ACTRZY805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRTS705 route compound structure diagram
    ACNRTS705328-74-5 In Stock
  2. Plus
  3. ACSYFI840 route compound structure diagram
    ACSYFI840622-78-6 In Stock
  4. Then
  5. ACTRZY805 route product structure diagram
    ACTRZY80513571-44-3 In Stock
Inquiry

Comments (0)